Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.370
-0.020 (-1.44%)
At close: Nov 26, 2025, 4:00 PM EST
1.360
-0.010 (-0.73%)
After-hours: Nov 26, 2025, 7:59 PM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $364.62 million as of November 26, 2025. Its market cap has decreased by -63.26% in one year.
Market Cap
364.62M
Enterprise Value
322.38M
1-Year Change
-63.26%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $364.62M, a decrease of -62.40%. That is a compound annual growth rate of -12.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 369.94M | -40.85% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | 467.55M | -21.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |